Stocks
Evolent Health (EVH) R&D/CAPEX US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| R&D/CAPEX, % | 55.7% | 51.2% | 62.0% | 70.4% | 92.9% | 105.0% | ||
| Changes by years, y/y, % | -4pp | +11pp | +8pp | +23pp | ||||
Evolent Health. R&D/CAPEX, %
Evolent Health. R&D/CAPEX, changes, pp
Evolent Health (EVH) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 74.0% | 99.3% | 97.2% | 109.1% | 117.8% | 105.0% | ||
| Changes by years, y/y, % | +40pp | +44pp | ||||||
| Changes by quarters, q/q, % | +25pp | -2pp | +12pp | +9pp | ||||
